AzTrials
AzTrials

FractureNCT05538403

AI Performance for the Detection of Bone Fractures in Children

An observational study of Fracture, run by University Hospital, Montpellier at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The artificial intelligence (AI) software BoneView (GLEAMER Company, Paris, France) has been designed, tested and validated to detect and locate recent or semi-recent fractures on standard radiographs. Read more about this study

Who is it for?
Ages 0 to 2 years
Conditions the study is for
Fracture
How many people
210 participants
Where
1 siteFrance
Study dates
1 May 2022to 30 Dec 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 2 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children aged less than 2 years old in suspected child abuse setting

Who may be able to join

  • aged less than 2 years old
  • whole body radiography performed for suspected child abuse setting
  • report available with a double blind reading (generalist radiologist and radiologist with expertise in child abuse)

Who cannot join

  • Radiograph not interpretable ( poor quality)
  • AI not applicable

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • University hospital

    Montpellier, 34295

    Ingrid Millet, PUPH, 0678887174 ext. 33, i-millet@chu-montpellier.fr

    Recruiting

Other trials in France

About this study

Official title: Assessment of AI Performance for the Detection of Bone Fractures in Children Aged Less Than 2 Years Old in Suspected Child Abuse Setting.

The artificial intelligence (AI) software BoneView (GLEAMER Company, Paris, France) has been designed, tested and validated to detect and locate recent or semi-recent fractures on standard radiographs.

The objective will be to assess the AI performance for the detection of bone fractures in children aged less than 2 years old in suspected child abuse setting.

Read more

These patients benefit from a whole body radiography with a double blind reading by a "generalist" radiologist and a radiologist with expertise in child abuse. This readings will be compared with the AI results.

Hypothesis is that AI is effective for child fractures detection and could be of help especially for radiologists who are not experts in child abuse.

Conditions
Fracture
Keywords
Aged, Radiography, Paediatric imaging, Artificial intelligence, child abuse
Medical subject headings
Fractures, Bone

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of fracture detected by AI on radiographs

    Percentage of fracture detected by AI on radiographs

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Sep 2022
  2. Study start1 May 2022
  3. Primary completion1 Nov 2022 (estimated)
  4. Study completion30 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
210 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05538403
Sponsor's protocol ID
RECHMPL22_0224
Status last verified
Sep 2022
First submitted
9 Sep 2022
Last updated
13 Sep 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: NC

Questions about this trial

What is this clinical trial studying?

An observational study of Fracture, run by University Hospital, Montpellier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ingrid Millet, PUPH (678887174 ext. 33, i-millet@chu-montpellier.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of fracture detected by AI on radiographs (time frame: 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in